Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Authors :
Mathieu C; Department of Endocrinology, UZ Gasthuisberg, Leuven, Belgium.; Ahmed W
Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy; Humans
-
Source:
Diabetes technology & therapeutics [Diabetes Technol Ther] 2024 Mar; Vol. 26 (S3), pp. 66-75.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print Cited
Record details
-
Authors :
Cobry EC; Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Pyle L
Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/complications; Adult
-
Source:
Diabetes technology & therapeutics [Diabetes Technol Ther] 2024 Feb; Vol. 26 (2), pp. 119-124. Date of Electronic Publication: 2024 Jan 19.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic
Record details
-
Authors :
Li A; Department of Endocrinology, Peking University First Hospital, Beijing, China.; Li X
Subjects: Blood Glucose* ; Diabetes Mellitus, Type 2*; Humans
-
Source:
Diabetes technology & therapeutics [Diabetes Technol Ther] 2024 Feb; Vol. 26 (2), pp. 103-111. Date of Electronic Publication: 2024 Jan 03.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic
Record details
-
Authors :
Davis GM; Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.; Hughes MS
Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Diabetic Ketoacidosis* ; Hypoglycemia*/Hypoglycemia*/Hypoglycemia*/chemically induced
-
Source:
Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 Oct; Vol. 25 (10), pp. 677-688. Date of Electronic Publication: 2023 Aug 28.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic
Record details
-
Authors :
Kovatchev B; Center for Diabetes Technology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.; Lobo B
Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy; Humans
-
Source:
Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 Aug; Vol. 25 (8), pp. 519-528.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print Cited
Record details
-
Authors :
Donaldson LE; Department of Medicine, The University of Melbourne, Melbourne, Australia.; Department of Endocrinology and Diabetes, St Vincent's Hospital Melbourne, Melbourne, Australia.
Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Hypoglycemia*/Hypoglycemia*/Hypoglycemia*/diagnosis; Humans
-
Source:
Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 Jul; Vol. 25 (7), pp. 497-506. Date of Electronic Publication: 2023 May 08.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic
Record details
-
Authors :
Bergenstal RM; International Diabetes Center, HealthPartners Institute, 3800 Park Nicollet Blvd, Minneapolis, Minnesota, USA.; Hachmann-Nielsen E
Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Hypoglycemia*/Hypoglycemia*/Hypoglycemia*/etiology
-
Source:
Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 Jun; Vol. 25 (6), pp. 378-383. Date of Electronic Publication: 2023 May 08.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic
Record details
-
Authors :
Pathak S; Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, North Carolina, USA.; Kearin K
Subjects: Diabetes Mellitus, Type 2* ; Diabetes Mellitus, Type 1*; Humans
-
Source:
Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 Mar; Vol. 25 (3), pp. 169-177. Date of Electronic Publication: 2023 Jan 04.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic
Record details
-
Authors :
Polonsky WH; Behavioral Diabetes Institute, San Diego, California, USA.; University of California, San Diego, California, USA.
Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/psychology ; Diabetes Mellitus, Type 2* ; Self-Management*
-
Source:
Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 Mar; Vol. 25 (3), pp. 194-200. Date of Electronic Publication: 2022 Dec 12.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic
Record details
-
Authors :
Forlenza GP; Barbara Davis Center, Division of Pediatric Endocrinology, Department of Pediatrics, University of Colorado Denver, Denver, Colorado, USA.; Carlson AL
Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy; Humans
-
Source:
Diabetes technology & therapeutics [Diabetes Technol Ther] 2022 Nov; Vol. 24 (11), pp. 814-823. Date of Electronic Publication: 2022 Jul 26.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic
Record details
-
Authors :
Montaser E; Center for Diabetes Technology, School of Medicine, University of Virginia, Charlottesville, Virginia, USA.; Fabris C
Subjects: Diabetes Mellitus, Type 2* ; Hypoglycemia* ; Hyperglycemia*
-
Source:
Diabetes technology & therapeutics [Diabetes Technol Ther] 2022 Nov; Vol. 24 (11), pp. 797-804. Date of Electronic Publication: 2022 Jul 05.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic
Record details
-
Authors :
Lanzinger S; Institute of Epidemiology and Medical Biometry, ZIBMT, Ulm University, Ulm, Germany.; German Centre for Diabetes Research (DZD), München-Neuherberg, Germany.
Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy
-
Source:
Diabetes technology & therapeutics [Diabetes Technol Ther] 2022 Oct; Vol. 24 (10), pp. 763-769. Date of Electronic Publication: 2022 Jul 08.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic
Record details
-
Authors :
Lynch J; Department of Pediatrics, University of Texas Health Sciences Center, San Antonio, San Antonio, Texas, USA.; Kanapka LG
Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/drug therapy ; Insulin*/Insulin*/Insulin*/therapeutic use; Adolescent
-
Source:
Diabetes technology & therapeutics [Diabetes Technol Ther] 2022 Oct; Vol. 24 (10), pp. 726-736.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print Cited
Record details